Philanthotoxin 74

Philanthotoxin 74 is a synthetic analog of naturally occurring philanthotoxins, originally isolated from the venom of the solitary wasp Philanthus triangulum. Structurally, it features a polyamine backbone attached to a phenyl group, which allows for selective interaction with ionotropic receptors, particularly those related to excitatory neurotransmission. This compound is renowned in neuropharmacological research for its potent antagonistic properties against various ligand-gated ion channels, including AMPA, kainate, and NMDA receptors. Its unique mode of action enables researchers to dissect the roles of specific receptor subtypes in synaptic transmission and plasticity, making it a valuable chemical tool in both in vitro and in vivo experimental systems. Philanthotoxin 74 is widely utilized in the study of neuronal signaling pathways, providing insights into the molecular mechanisms underlying excitatory neurotransmission and neurotoxicity. Its versatility also extends to the investigation of receptor pharmacology and the development of novel neuroactive agents.

Neurophysiology Research: Philanthotoxin 74 serves as a powerful tool in neurophysiology for elucidating the functional roles of ionotropic glutamate receptors. By selectively inhibiting AMPA and kainate receptor subtypes, researchers can use it to dissect synaptic currents and understand the dynamics of excitatory postsynaptic potentials. This capability is particularly valuable in electrophysiological experiments, such as patch-clamp recordings, where precise modulation of receptor activity is essential for mapping neural circuit function and plasticity. The compound's reversible and competitive antagonism allows for controlled studies of receptor-mediated signaling without causing permanent alterations to neuronal networks.

Ion Channel Pharmacology: In the field of ion channel pharmacology, philanthotoxin analogs are employed to characterize the selectivity and functional properties of ligand-gated ion channels. Scientists use this compound to probe the subunit composition and pharmacological profiles of AMPA, kainate, and NMDA receptors, facilitating the identification of novel modulatory sites and allosteric mechanisms. Such studies are crucial for the rational design of new compounds with improved specificity and therapeutic potential. The detailed insights gained from these investigations help advance the development of drugs targeting neurological disorders associated with dysfunctional glutamatergic transmission.

Synaptic Plasticity Studies: Researchers investigating the mechanisms of synaptic plasticity, such as long-term potentiation (LTP) and long-term depression (LTD), often employ philanthotoxin 74 to selectively manipulate postsynaptic receptor activity. By transiently blocking specific receptor subtypes, it is possible to delineate the contributions of AMPA and NMDA receptors to synaptic strength and plastic changes. These studies are fundamental for understanding learning and memory processes at the molecular and cellular levels. The use of this compound in such experiments enables precise temporal control over receptor function, which is critical for dissecting the sequence of events underlying synaptic modifications.

Neurotoxicity and Excitotoxicity Models: Philanthotoxin 74 is instrumental in modeling neurotoxicity and excitotoxicity, conditions characterized by excessive activation of glutamate receptors leading to neuronal damage. By antagonizing these receptors, researchers can investigate the pathways involved in cell death and survival, identify protective mechanisms, and evaluate the efficacy of neuroprotective strategies. The compound's ability to modulate excitatory signaling makes it an indispensable tool in studies aimed at unraveling the pathophysiology of neurodegenerative diseases and acute neuronal injury.

Drug Discovery and Screening: In early-stage drug discovery, philanthotoxin derivatives are frequently used in high-throughput screening assays to identify novel compounds that modulate ionotropic glutamate receptors. These assays benefit from the compound's well-characterized pharmacological profile, which provides a reliable reference for comparing the activity of new molecules. The insights generated from such screens accelerate the identification and optimization of lead compounds for further development. Additionally, the use of philanthotoxins in these assays helps to validate target engagement and assess potential off-target effects, supporting the advancement of safer and more effective neuroactive agents.

1. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

2. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L